Literature DB >> 2483144

Electroretinography in central retinal vein occlusion. Correlation of electroretinographic changes with pupillary abnormalities.

S S Hayreh1, M R Klugman, P Podhajsky, H E Kolder.   

Abstract

In 149 eyes with central retinal vein occlusion (CRVO), we prospectively investigated the role of routine, clinical electroretinography (ERG) in differentiating ischemic (60 eyes) from nonischemic CRVO (89 eyes). Single-flash photopic and scotopic ERGs were recorded. Data for the amplitudes and implicit times of a- and b-waves and for the b-/a-wave amplitude ratio were analyzed in detail. The study revealed that the best ERG parameter (for both photopic and scotopic ERG) for differentiating ischemic from nonischemic CRVO was a subnormal b-wave amplitude (reduced to less than or equal to 60% or by greater than or equal to 1 SD from the normal mean value, or less than or equal to 64%-69% of that in the fellow normal eye), with a sensitivity of 80%-90% and a specificity of 70%-80%. ERG findings were correlated with the relative afferent pupillary defect (RAPD). An RAPD of greater than or equal to 0.7 log units showed a sensitivity of 88% and a specificity of 90% in differentiating ischemic from nonischemic CRVO. ERG and RAPD findings showed a good correlation. The combined ERG and RAPD tests could differentiate 97%-100% of ischemic from nonischemic CRVO cases, with a specificity of about 70%.

Entities:  

Mesh:

Year:  1989        PMID: 2483144     DOI: 10.1007/bf02169451

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  The clinical electroretinogram. VII. The electroretinogram in circulatory disturbances of the retina.

Authors:  G KARPE; A UCHERMANN
Journal:  Acta Ophthalmol (Copenh)       Date:  1955

2.  Relative afferent pupillary defect in central retinal vein occlusion.

Authors:  G E Servais; H S Thompson; S S Hayreh
Journal:  Ophthalmology       Date:  1986-03       Impact factor: 12.079

3.  Neovascularization in central retinal vein occlusion: electroretinographic findings.

Authors:  M A Johnson; S Marcus; M J Elman; T J McPhee
Journal:  Arch Ophthalmol       Date:  1988-03

4.  Occlusion of the central retinal vessels.

Authors:  S S Hayreh
Journal:  Br J Ophthalmol       Date:  1965-12       Impact factor: 4.638

5.  Central retinal artery occlusion and retinal tolerance time.

Authors:  S S Hayreh; H E Kolder; T A Weingeist
Journal:  Ophthalmology       Date:  1980-01       Impact factor: 12.079

6.  The relationship between visual acuity, pupillary defect, and visual field loss.

Authors:  H S Thompson; P Montague; T A Cox; J J Corbett
Journal:  Am J Ophthalmol       Date:  1982-06       Impact factor: 5.258

7.  So-called "central retinal vein occlusion". I. Pathogenesis, terminology, clinical features.

Authors:  S S Hayreh
Journal:  Ophthalmologica       Date:  1976       Impact factor: 3.250

8.  Temporal aspects of the electroretinogram in diabetic retinopathy.

Authors:  G H Bresnick; M Palta
Journal:  Arch Ophthalmol       Date:  1987-05

Review 9.  Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.

Authors:  S S Hayreh; P Rojas; P Podhajsky; P Montague; R F Woolson
Journal:  Ophthalmology       Date:  1983-05       Impact factor: 12.079

10.  Predicting progression to severe proliferative diabetic retinopathy.

Authors:  G H Bresnick; M Palta
Journal:  Arch Ophthalmol       Date:  1987-06
View more
  21 in total

1.  Wide field multifocal and standard full field electroretinographic features of hemi retinal vein occlusion.

Authors:  Fiona Mary Dolan; Stuart Parks; David Keating; Gordon Neale Dutton
Journal:  Doc Ophthalmol       Date:  2006-01       Impact factor: 2.379

2.  The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary.

Authors:  S Sivaprasad; W M Amoaku; P Hykin
Journal:  Eye (Lond)       Date:  2015-08-28       Impact factor: 3.775

3.  The photopic negative response of the flash electroretinogram in retinal vein occlusion.

Authors:  Hongling Chen; Dezheng Wu; Shizhou Huang; Hong Yan
Journal:  Doc Ophthalmol       Date:  2006-08-30       Impact factor: 2.379

4.  Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.

Authors:  S S Hayreh; M R Klugman; P Podhajsky; G E Servais; E S Perkins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

5.  Changes of electroretinogram without improvement of retinal circulation after radial optic neurotomy for central retinal vein occlusion. ERG changes after RON for CRVO.

Authors:  Eiju Sato; Shuichi Yamamoto; Kazuha Ogata; Mariko Kubota; Takeshi Sugawara; Satoshi Mizunoya
Journal:  Doc Ophthalmol       Date:  2008-01-01       Impact factor: 2.379

6.  The flicker electroretinogram interocular amplitude ratio is a strong prognostic indicator of neovascularization in patients with central retinal vein occlusion.

Authors:  Hsi-Kung Kuo; Ming-Tse Kuo; Yung-Jen Chen; Pei-Chang Wu; Chih-Hsin Chen; Yi-Hao Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-08       Impact factor: 3.117

7.  Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema.

Authors:  Hidetaka Noma; Hideharu Funatsu; Seiyo Harino; Takeshi Sugawara; Tatsuya Mimura; Katsunori Shimada
Journal:  Doc Ophthalmol       Date:  2011-07-30       Impact factor: 2.379

Review 8.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

9.  Rod and cone a-waves in central retinal vein occlusion.

Authors:  Naoyuki Tanimoto; Tomoaki Usui; Mikio Ichibe; Mineo Takagi; Keiko Suzuki; Shigeru Hasegawa; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

10.  Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase.

Authors:  S S Hayreh; M R Klugman; M Beri; A E Kimura; P Podhajsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.